相关实验视频

Updated: Jun 8, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

miR-3154通过向TP53INP1促进质母细胞瘤的扩散和转移

Xiangdan Lin^1,2, Qiong Wu³, Wei Lei¹

¹Department of Neurosurgery, General Hospital of Northern Theater Command, 83 Wenhua Road, ShenHe District, Shengyang, Liaoning, 110016, China.

|November 2, 2024

概括

一个新发现的微RNA,miR-3154,促进质母细胞瘤的生长和扩散. 针对miR-3154及其与TP53INP1的相互作用,为质母细胞瘤提供了潜在的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

质母细胞瘤 (GBM) 是一种具有攻击性的原发性脑瘤.
微RNAs (miRNAs) 参与了GBM的发生.
了解新的调节机制对于GBM治疗至关重要.

研究的目的:

为了研究一种新的miRNA,miR-3154,在质母细胞瘤中的作用.
阐明miR-3154影响GBM进展的分子机制.

主要方法:

在质母细胞瘤组织和细胞系中量化miR-3154表达.
在miR-3154 knockdown之后进行了体外功能测试 (增殖,殖民地形成,细胞周期,细胞亡,迁移,入侵).
涉及miR-3154与TP53INP1mRNA和蛋白质水平直接结合的机制研究.
验证TP53INP1在调解miR-3154效应中的作用.

主要成果:

miR-3154表达在质母细胞瘤中升高,与瘤等级相关.
miR-3154 knockdown 抑制质母细胞瘤细胞增殖,殖民地形成,并诱导细胞亡和细胞循环停止.
miR-3154 knockdown 损害了质母细胞瘤细胞迁移和入侵.
miR-3154直接向并降低瘤蛋白P53诱导核蛋白1 (TP53INP1) 的调节.
TP53INP1倒置逆转了miR-3154抑制的抗瘤作用.

结论:

miR-3154在质母细胞瘤中充当致癌性miRNA.
miR-3154通过向TP53INP1.1,促进质母细胞瘤的扩散和转移.
准miR-3154/TP53INP1轴为质母细胞瘤提供了一个潜在的治疗策略.

关键词:

质母细胞瘤 (glioblastoma) 是一个转移转移转移转移核武器的扩散在TP53INP1中使用.在 miR-3154 的位置上.

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...